Patlytics

Pros & Cons

Pros

  • Purpose-Built for IP: Covers the full patent lifecycle (search, drafting support, infringement/invalidity analysis, portfolio management) rather than being a general legal AI tool adapted for patents.
  • Strong Enterprise Adoption: Reports usage by more than 40% of Am Law 100 IP practices, a meaningful validation signal for a company founded in 2023.
  • Well-Capitalized: Roughly $65 million raised in under two and a half years, including a $40 million Series B with strategic backing from Relativity.
  • Portfolio-Level Risk Scoring: Infringement and invalidity analysis can help IP teams prioritize which patents in a large portfolio carry the most risk.

Cons

  • No Public Pricing: Patlytics does not publish pricing, so smaller firms cannot easily gauge affordability without contacting sales.
  • Limited Independent Reviews: As a young, enterprise-sold product, it lacks the volume of G2/Capterra reviews available for more established legal AI tools.
  • Narrow Scope: Being IP-specific, it does not address general legal research, contract analysis, or litigation needs outside the patent domain.

About Patlytics

Introduction

Patlytics is an AI platform built specifically for intellectual property work, covering the full patent lifecycle from prior-art search and invention disclosure through drafting support, infringement and invalidity analysis, claim charting, and portfolio management. Founded in San Francisco in 2023, the company has grown quickly among IP-focused law firms, reporting adoption by more than 40% of Am Law 100 IP practices, and closed a $40 million Series B in April 2026 (bringing total funding to roughly $65 million) with backing from SignalFire and IP-adjacent investor Relativity.

Legal Research & Patent Analytics

Patlytics' core strength is patent-specific search and analytics: prior-art discovery, claim charting, and infringement/invalidity analysis across large patent corpora. Because it is purpose-built for IP rather than general legal research, it is positioned as a complement to (not a replacement for) broader legal research tools like Westlaw or Lexis+.

Predictive Analytics

Invalidity and infringement risk scoring gives Patlytics a predictive-analytics dimension distinct from most general legal AI tools: it is designed to help IP counsel triage which patents in a large portfolio carry the most litigation or licensing risk. As with any AI risk-scoring tool, outputs should be treated as a prioritization aid rather than a substitute for attorney judgment.

Pricing

Patlytics does not publish list pricing. As an enterprise IP platform sold primarily to Am Law 100 firms and corporate patent departments, pricing is quote-based and likely scales with portfolio size and the number of users; prospective customers should request a custom quote.

User Reviews and Ratings

Patlytics does not yet have a significant public review footprint on sites like G2 or Capterra, which is typical for a young, enterprise-focused IP tool sold through direct sales rather than self-serve signup. Its main public validation to date is its funding roster (including Relativity as a strategic investor) and its stated adoption inside a large share of top IP practices, rather than independent user-review scores.

Verdict

Patlytics is one of the best-funded and most IP-specific AI platforms on the market, with real traction inside major IP practices, making it a strong option for firms and corporate patent teams that want dedicated tooling for patent search, risk scoring, and portfolio management. It is a narrower fit for generalist firms without a significant patent practice, and buyers should go in expecting custom enterprise pricing and limited independent review data to benchmark against.

Frequently Asked Questions

Patlytics is an AI platform covering the full patent lifecycle: prior-art search, drafting support, infringement and invalidity analysis, claim charting, and patent portfolio management, aimed at IP law firms and corporate patent departments.

Patlytics states that more than 40% of Am Law 100 IP practices use its platform, alongside corporate in-house patent teams; it is built for organizations with meaningful patent portfolios rather than solo practitioners.

Patlytics does not publish pricing publicly. As an enterprise platform sold to law firms and corporate legal departments, pricing is quote-based and depends on portfolio size and number of users.

Founded in San Francisco in 2023, Patlytics has raised approximately $65 million across its funding history, including a $40 million Series B in April 2026 led by SignalFire with participation from Relativity, Myriad Venture Partners, and others.

Reviews